SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotime-Nasdaq's best kept secret?
BTIM 0.00010000.0%Nov 5 1:26 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Stephen How who wrote (924)5/8/1998 8:47:00 AM
From: Saul H Rosenthal  Read Replies (1) of 1432
 
Here's his profile:

David Crossen is a Senior Managing Director and Senior Research Analyst
in the Health Care Group at NationsBanc Montgomery Securities, where he
follows biotechnology companies. Amgen, Inc., North American Vaccine,
Inc., Biochem Pharma and The Liposome Company are among the companies in
Crossen's current research coverage.

Crossen joined NationsBanc Montgomery Securities in 1995. Prior to
joining NationsBanc Montgomery, Crossen served as a Managing Director
and Director of Health Care Research at UBS Securities. He was CEO of
Cortech, Inc. for six years and a Pharmaceutical Analyst and Partner at
Sanford C. Bernstein & Co.

Sorry, but he doesn't sound like a dummy to me!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News